Role of MTA2 in human cancer

Kyle R Covington1, Suzanne A W Fuqua

  • 1Lester and Sue Smith Breast Center, One Baylor Plaza, Baylor College of Medicine, 1220 N. Alkek, MS: 600, Houston, TX, 77030, USA, covingto@bcm.edu.

Cancer Metastasis Reviews
|November 15, 2014
PubMed

Insights

Metastasis, the spread of cancer, is poorly understood. This study highlights the role of Metastasis Tumor-Associated protein 2 (MTA2) in linking cellular structure and gene regulation, crucial for cancer cell dissemination.

Area of Science:

  • Oncology
  • Molecular Biology
  • Cell Biology

Background:

  • Metastasis is the primary cause of cancer-related mortality.
  • Mechanisms regulating primary tumor growth are known, but metastasis processes remain largely unelucidated.
  • Cancer cell dissemination involves dynamic alterations in cellular processes, including cytoskeletal dynamics and cell-environment interactions.

Purpose of the Study:

  • To investigate the role of Metastasis Tumor-Associated protein 2 (MTA2) in cancer metastasis.
  • To explore MTA2's function as a central regulator linking nuclear transcription and cytoskeletal organization.
  • To specifically examine MTA2's involvement in breast cancer metastasis.

Main Methods:

  • Focus on the protein MTA2 and its function within the cell.
  • Analysis of MTA2's role in the nucleosome remodeling and histone deacetylation complex.
  • Investigating the link between MTA2, cytoskeletal organization, and transcriptional regulation.

Main Results:

  • MTA2 is a key component of the Nucleosome Remodeling and Deacetylation (NuRD) complex.
  • MTA2 acts as a central hub connecting cytoskeletal organization with transcriptional control.
  • MTA2 facilitates the dynamic cellular changes necessary for metastasis.

Conclusions:

  • MTA2 plays a critical role in mediating the cellular alterations required for metastasis.
  • Understanding MTA2's function provides insights into the molecular mechanisms of cancer spread.
  • Targeting MTA2 may offer therapeutic strategies for inhibiting breast cancer metastasis.

Related Concept Videos

mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
5.2K
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

1.8K
Electron Transport Chain: Complex I and II01:46

Electron Transport Chain: Complex I and II

The mitochondrial electron transport chain (ETC) is the main energy generation system in the eukaryotic cells. However, mitochondria also produce cytotoxic reactive oxygen species (ROS) due to the large electron flow during oxidative phosphorylation. While Complex I is one of the primary sources of superoxide radicals, ROS production by Complex II is uncommon and may only be observed in cancer cells with mutated complexes.
ROS generation is regulated and maintained at moderate levels necessary...
19.8K
Mitogens and the Cell Cycle02:38

Mitogens and the Cell Cycle

Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
8.5K
Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
5.5K
PI3K/mTOR/AKT Signaling Pathway01:22

PI3K/mTOR/AKT Signaling Pathway

The mammalian target of rapamycin  (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1  (mTORC1) and mTOR complex 2  (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast,  mTORC2 consists of a...
6.5K